Probe · Predict · Prevent
We are developing the first adaptive neuromodulation therapy that is able to both predict and prevent seizures in people suffering from uncontrolled epilepsy
Dual-Function Neuromodulation System That Both Predicts and Prevents Epileptic Seizures
Our breakthrough technology consists of an intracranially implantable neuromodulation device that probes the brain with electrical pulses intermittently, predicts seizures based on the brain’s response, and prevents them through therapeutic stimulation.
First-in-Human Study
We conducted the first human study in a cohort of eight people with drug-resistant epilepsy at King’s College Hospital, London.
Clinical Findings:
Proved for the FIRST time that active probing enables significantly more accurate seizure prediction compared to existing passive techniques
Setting Precedent:
Demonstrated that tracking the brain’s response to electrical stimulation is safe, ethically permissible, and well-tolerated by patients
Our Team
Research Fellow in the Departments of Health Informatics and Biostatistics
Basic and Clinical NeuroscienceChief Executive Officer
Chief Medical Officer
Professor of Epilepsy
Head of School of Neuroscience
Chief Scientific Officer
Senior Lecturer in Clinical Neurophysiology
Honorary Clinical Neurology Consultant
Professor of Engineering
Royal Academy of Engineering Chair in Emerging TechnologiesAdvisor
Advisor
Professor of Medical Bioinformatics
Head of Bioinformatics and Biostatistics Department
Advisor
Professor of Active Implantable Medical Devices
Director of MAISI
Assistant Professor of Neurological Surgery
Adjunct Assistant Professor of Electrical & Computer EngineeringAdvisor
Advisor
CEO & Co-Founder at MintNeuro
Visiting Researcher at Imperial College LondonOur Partners
-
King's College London
-
King's Health Partners
-
King's College Hospital
-
CorTec
Contact Us
Get in touch